Surgical outcomes from robotic-assisted adrenalectomy: a case series on experience in a large tertiary referral centre
Surgical Endoscopy · 2025
DOI: 10.1007/s00464-024-11403-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Endoscopy, 2025. Verfasst von Sandeep K Maharajh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine and General Surgery Department, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK. Sandeep.mahara…. Hauptthemen laut MEDLINE: Adrenalectomy, Robotic Surgical Procedures, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Robotic-assisted surgery is gaining wider acceptance in most surgical specialties. However, in the United Kingdom, endocrine surgery has not fully adopted robotics. This paper aims to present the early experience and outcomes of patients who underwent robotic-assisted adrenalectomy at a tertiary referral endocrine surgery department. Outcomes were compared to national and international performance measures. METHODS: Seventy-two elective robotic adrenalectomies were performed over a 24-month period. Data collected included patient demographics, co-morbidities, indication for surgery and tumour size. Outcomes assessed were console time, conversion rates, complications, length of stay and excision margin. RESULTS: Seventy-two cases were included for analysis. Sixty-six percent (n = 48) of the patients were female with a median age of 60 years. Median BMI was 28. Functional tumours accounted for 76% (n = 55) of cases with the most common being phaeochromocytomas and cortisol producing adenomas. Median docking time was 5 min with a median intraoperative time on the console of 45.5 min. Tumour size ranged from 1 to 14 cm. Median length of stay postoperatively was 1 day. There was only one conversion to open procedure. Two patients reported post-op superficial surgical site infections and there were no mortalities. CONCLUSION: This case series demonstrates robotic-assisted adrenalectomies performed in a tertiary care centre were safe and feasible in a selected cohort of patients with functional and non-functional tumours. Large randomised controlled trials with long-term follow-up are required to establish the benefits of robotic adrenal surgery over conventional laparoscopic adrenalectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrine and General Surgery Department, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK. Sandeep.maharajh@nhs.net.
- , Flat 28 Ashburne House, Oxford Place, Manchester, M14 5SF, UK. Sandeep.maharajh@nhs.net.
- Endocrine and General Surgery Department, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
ORCID-Profile: Sandeep K Maharajh
Zitieren
APA
Maharajh, S. K., Ashoush, F., & Ramsingh, J. K. (2025). Surgical outcomes from robotic-assisted adrenalectomy: a case series on experience in a large tertiary referral centre. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-11403-8
Vancouver
Maharajh SK, Ashoush F, Ramsingh JK. Surgical outcomes from robotic-assisted adrenalectomy: a case series on experience in a large tertiary referral centre. Surgical Endoscopy. 2025. doi:10.1007/s00464-024-11403-8
BibTeX
@article{Maharajh2025,
author = {Maharajh, Sandeep K and Ashoush, Fouad and Ramsingh, Jason K},
title = {Surgical outcomes from robotic-assisted adrenalectomy: a case series on experience in a large tertiary referral centre},
journal = {Surgical Endoscopy},
year = {2025},
doi = {10.1007/s00464-024-11403-8}
}
EUVIMED